This report provides a comprehensive overview of the ocular drug delivery segment and includes detailed product and technology information, market data, DDS pipelines by therapeutic category, company profiles, and partnering opportunities.
It is an exciting time in the field of ocular drug delivery, with a number of innovative delivery systems showing promise. The market is currently dominated by topical products such as drops and ointments which are inefficient and can be difficult tadminister properly. Injectable formulations are available ta lesser extent and can be associated with serious side effects and require administration by a medical professional.
Fortunately there are a record number of companies developing improved ocular delivery systems which provide benefits such as sustained release, accurate dosing, and ease of administration. These companies range from emerging start-ups with preclinical projects testablished specialty companies with late-stage pipeline products.
Collectively, these companies have more than 70 novel ocular formulations and products in various stages of development for indications such as glaucoma, uveitis, macular degeneration, and dry eye disease.
Overview and prevalence data
Marketed therapeutics by indication
Age-related macular degeneration
Ophthalmic Market Overview
Sales of top ten ophthalmic products, 2015-2016
Key players by revenue
Key players with drug delivery-enabled products
Ocular Drug Delivery Landscape
Non-invasive and invasive delivery technologies
Approved ocular drug delivery formulations
Ocular drug delivery pipeline by therapeutic category
Future perspectives and development opportunities
46 Company Profiles by Technology Type
Novel aerosol and eye drop devices
Topical delivery systems
Injectables and implants
For each company profiled, the following information is provided:
Development Status / Pipeline Products
Patents and Publications
Business Development & Licensing Contact
Sample of Companies Profiled:
Leo Lens Technology
Reasons to Buy:
Identify enabling delivery systems or devices for pipeline drugs
Scout technologies for life cycle management of commercialized ophthalmic drugs
Understand the key players and therapeutic segments
Obtain product and technology information for launched ophthalmics
View pipeline details for novel ocular formulations in development
Discover product and technology licensing opportunities